For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260609:nRSI4012Ha&default-theme=true
RNS Number : 4012H Fevertree Drinks PLC 09 June 2026
9(th) June 2026
Fevertree Drinks plc
("Fever-Tree" or the "Company")
Transaction in Own Shares
Fevertree Drinks plc ("Fever-Tree" or the "Company") announces today it has,
in accordance with the authority granted by shareholders at its 2025 Annual
General Meeting held on 5(th) June, purchased the following number of ordinary
shares of £0.0025 each in the Company (the "Ordinary Shares") through the
Company's broker, Investec Bank plc ("Investec") in the period from 1(st) June
to 5(th) June 2026.
Date Venue Volume-weighted average price (p) Aggregated volume Lowest price per share (p) Highest price per share (p)
01 June 2026 XLON 768.4415 24,843 760.0000 781.0000
01 June 2026 AIMX 771.0000 20,000 771.0000 771.0000
02 June 2026 XLON 756.1103 44,120 746.0000 767.5000
03 June 2026 XLON 750.5514 26,893 745.0000 758.0000
04 June 2026 XLON 746.6340 40,668 740.5000 753.0000
04 June 2026 AIMX 746.5000 3,364 746.5000 746.5000
05 June 2026 XLON 750.9454 25,477 740.0000 758.0000
05 June 2026 AIMX 756.5000 30,000 756.5000 756.5000
The Company intends to cancel the purchased shares.
Schedule of Purchases - Individual Transactions
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market
Abuse Regulation) (which forms part of domestic UK law by virtue of the
European Union (Withdrawal) Act 2018, as amended), a full breakdown of the
individual trades made by Investec on behalf of the Company as part of the
share buyback programme is attached to this announcement.
http://www.rns-pdf.londonstockexchange.com/rns/4012H_1-2026-6-8.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/4012H_1-2026-6-8.pdf)
This announcement does not constitute, or form part of, an offer or any
solicitation of an offer for securities in any jurisdiction.
For further information please contact:
Investor queries
Steve Nightingale, Director of Investor Relations I
steve.nightingale@fever-tree.com I +44 (0)7951 849564
Media queries
Oliver Winters, Director of Communications I oliver.winters@fever-tree.com I
+44 (0)770 332 9024
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSKVLBBQQLBBBE
Copyright 2019 Regulatory News Service, all rights reserved